Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Hematopoietic stem cells I. Basal aspects].

G Olesen¹, M S Holm, P Hokland

¹Arhus Amtssygehus, Arhus Universitetshospital, haematologisk afdeling B.

Ugeskrift for Laeger

|February 19, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026

Same author

Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia.

International journal of laboratory hematology·2016

Same author

Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study.

Leukemia·2014

Same author

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Blood cancer journal·2014

Same author

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Leukemia·2013

Same author

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

British journal of cancer·2012

Hematopoietic stem cells (HSCs) are crucial for restoring blood cell production after cancer treatments. This review details methods for identifying and quantifying these vital stem cells for therapeutic use.

Area of Science:

Hematology
Stem Cell Biology
Immunology

Context:

Significant advancements in understanding hematopoietic stem cells (HSCs) over the past decade.
HSCs are now standard therapy for restoring hematopoiesis post-myeloablative chemotherapy and irradiation in cancer patients.
Characterization of HSCs is essential for their clinical application.

Purpose:

To review and describe the assays developed for characterizing and quantifying immature HSCs.
To provide a basis for the clinical application of HSCs.
To highlight the importance of both phenotypic and functional assays in HSC assessment.

Summary:

HSCs are vital for reconstituting the hematopoietic system after intensive cancer therapies.
Methods for HSC identification include immunophenotyping and flow cytometry to isolate HSC-enriched populations.

Related Experiment Videos

Functional assays (in vitro and in vivo) are critical as phenotypic markers alone do not fully predict HSC developmental potential, assessing their clonogenic proliferation and differentiation capacity.

Impact:

Improved understanding and application of HSCs in treating malignant disorders.
Provides a foundation for the development and refinement of HSC-based therapies.
Enhances the ability to accurately assess HSC quality and quantity for clinical transplantation.